Prognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy

Basit Öğe Kaydı
dc.authorid0000-0003-2143-5268
dc.authorid0000-0001-6047-2796
dc.contributor.authorÜskent, Necdet
dc.contributor.authorAyla, Şule
dc.contributor.authorMandel, Nil Molinas
dc.contributor.authorÖzkan, Metin
dc.contributor.authorTeomete, Mehmet
dc.contributor.authorBaloğlu, Hüseyin
dc.contributor.authorAydinçer, Cenk
dc.contributor.authorYergök, H.
dc.contributor.authorDoğan, Erkan
dc.contributor.authorBerk, Barkın
dc.contributor.authorYazar, Aziz
dc.date.accessioned2019-12-24T11:25:10Z
dc.date.available2019-12-24T11:25:10Z
dc.date.issued2019
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Histoloji ve Embriyoloji Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Farmasötik Kimya Ana Bilim Dalı
dc.descriptionConference Conference: 44th Congress of the European-Society-for-Medical-Oncology (ESMO) Location: Barcelona, SPAIN Date: SEP 27-OCT 01, 2019 Sponsor(s):European Soc Med Oncol; Japanese Soc Med Oncol
dc.description.abstract[Abstract Not Available]
dc.identifier.citationÜskent, N., Ayla, Ş., Mandel, N. M., Özkan, M., Teomete, M., Baloğlu, H. ... Yazar, A. (2019). Prognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy. 44th Congress of the European-Society-for-Medical-Oncology (ESMO). Barcelona, Spain, September 27-October 01, 2019.
dc.identifier.issn1569-8041
dc.identifier.issn0923-7534
dc.identifier.issueSupplement: 5
dc.identifier.urihttps://hdl.handle.net/20.500.12511/4649
dc.identifier.volume30
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartof44th Congress of the European-Society-for-Medical-Oncology (ESMO)en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectTumour Tissue
dc.subjectNeuGcGM3
dc.subjectGanglioside Expression
dc.subjectImmunotherapy
dc.titlePrognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy
dc.typeConference Object

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Berk-Barkın-2019.pdf
Boyut:
60.35 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Bildiri Koleksiyonu
Eczacılık Fakültesi Bildiri Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu